Bovine Torovirus (BoTV) is an uncultivable enteric pathogen of cattle. Its failure to grow in vitro limits epidemiological studies, characterization of the virus, and development of diagnostic techniques. The objectives of this study were to develop and standardize an antigen-capture enzyme-linked immunosorbent assay (ELISA) and a reverse transcriptase-polymerase chain reaction (RT-PCR) assay for the detection of BoTV in fecal specimens. These assays were compared with immunoelectron microscopy (IEM) to evaluate their sensitivity, specificity, and efficiency as well as their advantages and limitations. Additionally, several methods to calculate ELISA cutoff values were used and compared using a statistical approach to obtain the optimal cutoff value for the ELISA. A plate cutoff ELISA value was determined to be the best method to calculate the cutoff value. The ELISA and RT-PCR assays developed in this study identified BoTV antigen and viral nucleic acids in feces without cross-reactions with the other calf enteric viruses examined. Both assays showed good agreement with IEM, with a Kappa value of 0.86 for ELISA and 0.85 for RT-PCR. The latter exhibited the higher analytical sensitivity. On the basis of the results obtained in this study, it is recommended that no single test should be used alone in an epidemiological survey because of the observed limitations of each assay. The fast and inexpensive ELISA combined with the highly specific and sensitive RT-PCR are a practical approach for future epidemiological studies of BoTV. These results should provide other researchers with the information needed to develop similar diagnostic assays for the study of BoTV.
Toroviruses have been detected in humans, horses, cattle, and swine worldwide. 1, 3, 4, 11, 12, 18, 23 In cattle this enteric pathogen produces mild-to-moderate diarrhea in calves under both experimental and field conditions. 14, 19, 22, 24, 26, 28, 31, [33] [34] [35] Bovine torovirus (BoTV) is an enveloped, single-stranded RNA virus in the Torovirus genus within the Coronaviridae family, which produces cytolytic infections of villi and crypt enterocytes in the small and large intestine. [5] [6] [7] At present the inoculation of gnotobiotic (Gn) or colostrum deprived (CD) calves is the only way to propagate and maintain this virus. 17 Therefore, the large-scale preparation of reference antisera and antigens for the development of diagnostic tests has been precluded because BoTV does not grow in tissue (organ) culture, cell culture, or in embryonated eggs. 17, 32 This fact has limited the study of BoTV, 8 leaving many unanswered questions about its epidemiology and relative importance in different age-groups of infected cattle. To study the epidemiology and characterize this virus, rapid and simple diagnostic techniques for the detection of BoTV are needed. The objectives of this study were to design, standardize, and validate an indirect double sandwich antigen-capture enzyme-linked immunosorbent assay (ELISA) and a reverse transcriptase-polymerase chain reaction (RT-PCR) assay for the detection of BoTV in fecal specimens of cattle. Each test's sensitivity and specificity were calculated using samples from Gn and CD calves of known BoTV infection status, which was determined by immunoelectron microscopy (IEM) as the ''gold standard'' test. In addition, the observed advantages and limitations of the assays were described. Several methods to calculate cutoff values were used and compared using a statistical approach to determine the optimal cutoff value that allowed us to optimize the sensitivity and specificity of the ELISA.
Materials and methods

Preparation of guinea pig hyperimmune sera
Source of animals and virus. Adult female specific-pathogen-free guinea pigs (GPs) were obtained from a commercial source. a Bovine Torovirus serotype II (Ohio strain) (BO-4761) was obtained from the stools of an experimentally infected Gn calf (B-408), in which no other enteric viruses were detected by electron microscopy. Sucrose density gradient centrifugation was used to semipurify the BoTV particles for use in GP inoculation. Briefly, a fecal sample with a high concentration of BoTV determined by IEM (BO-4761) was diluted 1:10 in sample buffer (0.05 M Tris-HCL, 0.1 M NaCl, 1 mM CaCl 2 ), pH 7.5, and vortexed for 30 sec at high speed. The fecal suspension was sonicated at 80 MHz for 30 sec and centrifuged at 1,200 ϫ g for 20 min at 4 C. The supernatant was collected, centrifuged at 6,000 ϫ g for 20 min at 4 C, and the liquid phase was pelleted through 20% sucrose by ultracentrifugation (113,000 ϫ g for 2 hr at 4 C). After centrifugation, the pellet was resuspended in 2 ml of sample buffer and the virus was purified by sucrose density gradient (20%, 30%, 40%, and 50%) ultracentrifugation (113,000 ϫ g for 2 hr at 4 C). After centrifugation, the observed bands (or fractions) were collected and examined for BoTV by using IEM and a hemagglutination (HA) test. The selected fractions were diluted in sample buffer and centrifuged at 210,000 ϫ g for 2 hr at 4 C, and the pellets were resuspended in sample buffer, aliquoted, and stored at Ϫ70 C.
Immune electron microscopy. The IEM was conducted using a procedure similar to that previously described. 27 Briefly, fecal samples were diluted 1:10 in 0.5 mM phosphate buffered saline (PBS), pH 7.2, and centrifuged (1, 200 ϫ g for 20 min at 4 C). The supernatants were filtered (0.45 m) and incubated with hyperimmune Gn calf anti-BoTV-II serum (1:500) overnight at 4 C. After incubation, the immune complexes were pelleted by ultracentrifugation (69,000 ϫ g for 35 min at 4 C), resuspended in 25 l of H 2 O and repelleted as above before resuspension in 25 l of H 2 O. The suspensions were mixed with an equal volume of 3% phosphotungstic acid, pH 7.0, placed on formvar-coated, carbonized copper grids, and observed using an electron microscope. b Virus titration by HA test. The HA test (microtiter method) was used to titrate BoTV positive fractions, using previously described techniques. 25 Briefly, 50 l of veronal buffer, pH 7, was added to each well of a 96-well U-bottom microtiter plate. c Then, 50 l of the sample was added to the first well (1:2 dilution), and serial 2-fold dilutions were made. The last column without virus was the red blood cell (RBC) control. Next, 50 l of a 0.5% suspension of mouse RBCs (washed 3 times with veronal buffer) was added to each well, and plates were incubated for 1 hr at 4 C after which the tests were read. The HA titer was expressed as the reciprocal of the highest sample dilution that caused complete HA. Negative and positive control samples were run on each test day.
Immunization protocol. For the production of hyperimmune anti-BoTV sera, 2 GPs were inoculated 5 to 7 times subcutaneously over a 7-10-wk period with purified BoTV. The first inoculum consisted of an equal volume of virus and complete Freund's adjuvant. The second inoculum consisted of an equal volume of virus and incomplete Freund's adjuvant. All remaining inoculations were done 1 week apart using virus without adjuvant. The collected sera were tested for antibody titers using a hemagglutination inhibition (HI) test. All sera were heat-inactivated (56 C for 30 min), aliquoted, and stored at Ϫ20 C. One uninoculated GP was bled to obtain negative control sera.
Preparation of bovine hyperimmune sera
Source of animals and virus. A cesarean-derived Gn calf was used for inoculation with BoTV serotype II (Ohio strain). The calf was first orally inoculated at 3 days of age with a 10% Gn calf passaged fecal suspension containing BoTV. No other enteric viruses were detected by electron microscopy in the Gn calf fecal suspension. A series of intramuscular and subcutaneous inoculations were done using purified BoTV obtained from the feces of this same calf. The protocol used for production of the hyperimmune anti-BoTV sera in the Gn calf was as follows: 3 wk after oral exposure to BoTV, the calf was inoculated 4 times during a 7-wk period with the purified BoTV. The first inoculum consisted of an equal volume of virus and complete Freund's adjuvant, and the second, third, and fourth inoculations consisted of equal volumes of virus and incomplete Freund's adjuvant. All inoculations were administered subcutaneously and intramuscularly. The calf was bled from the jugular vein before the first inoculation and weekly thereafter until terminal bleeding at euthanasia (under pentobarbital anesthesia). All sera were heat-inactivated (56 C for 30 min), aliquoted, and stored at Ϫ20 C. Blood from a mock-inoculated Gn calf was used as a negative control serum. The antibody titer against BoTV in the hyperimmune calf sera was determined by the HI test as described.
Purification of the gamma globulin fraction of the calf anti-BoTV serum. Ammonium sulfate precipitation was used to purify the immunoglobulins from the calf BoTV antiserum. 16 Briefly, the antiserum was centrifuged at 3,000 ϫ g for 30 min at 4 C. A saturated ammonium sulfate solution was added with stirring to the serum to a final concentration of 50%. The mixture was incubated at 4 C overnight and centrifuged at 3,000 ϫ g for 30 min. The supernatant was discarded, and the pellet was resuspended to 50% of the initial volume in PBS, pH 7.2, and was dialyzed against PBS overnight. The final ammonium sulfate-precipitated calf antiserum was aliquoted and stored at Ϫ20 C.
Hemagglutination inhibition titers to BoTV of the GPs and gnotobiotic calf antisera. Antibody titers against BoTV were determined by the HI test, modified from previously described techniques. 25 Briefly, 2-fold dilutions of pretreated serum (treated 1:5 with Kaolin and 50% mouse RBCs) were prepared in 25 l of veronal buffer in 96-well U-bottom plates. c Then, 25 l containing 8 HA units of the sucrose gradient purified fecal BoTV was added to each well and incubated for 1 hr at room temperature. Next, 50 l of a 0.5% suspension of mouse RBCs (washed 3 times with veronal buffer) were added to each well, and plates were incubated for 2 hr at 4 C after which the test was read. A standard positive control serum with known HI antibody titer to BoTV and a negative control (serum without antibodies to BoTV obtained from a Gn calf) were run on each test day. The mouse RBC control and the virus control (back titration) were tested on 1 plate. The HI titers were expressed as the reciprocal of the highest serum dilution that completely inhibited HA of BoTV.
Optimization of the ELISA test
Positive and negative reference fecal samples. Sixty-three BoTV positive or negative reference fecal samples were collected from experimentally inoculated CD or Gn calves. The presence of BoTV in the positive samples was confirmed by IEM. The fecal samples were diluted 1:10 in PBS, centrifuged (1,200 ϫ g for 20 min at 4 C), and the supernatants were stored at Ϫ20 C. Of the 63 fecal samples, 34 BoTVpositive samples were obtained at various times postexposure to BoTV from 9 Gn and 2 CD calves experimentally infected with BoTV serotype II. Twenty-nine BoTV-negative fecal samples were obtained from 8 Gn and 6 CD calves. These negative samples included 8 preinoculation feces, 3 from mock inoculated calves, 2 from calves exposed to BoTV-negative field fecal samples, and 16 fecal samples from calves experimentally inoculated with bovine coronavirus (BCV) (n ϭ 7), bovine rotavirus (n ϭ 4), and bovine enteric calicivirus (n ϭ 5).
Checkerboard titration for optimization and standarization of the ELISA test. Several combinations and dilutions of the GPs and bovine antisera were tested. The best combination with the highest sensitivity (highest difference between positive and negative fecal samples), lowest background, and highest dilution was selected for each reagent. The commercial conjugates used were: purified polyclonal rabbit anti-GP immunoglobulin G (IgG) peroxidase d and affinity purified peroxidase labeled goat anti-bovine IgG (HϩL). e Serial dilutions of each batch of conjugate were tested to determine the end point dilution that produced the highest signal and lowest background.
To determine the optimal reagent concentrations, varying dilutions were tested on the same plate. The BoTV positive or negative fecal samples were tested using each ELISA protocol. The optimal dilution of each reagent to maximize the signal for antibody positive-coated wells and minimize nonspecific reactions in antibody negative-coated wells was selected. During this process of optimization, different incubation periods (1-2 hr), temperatures (23-37 C), concentrations of blocking reagent (1-5% nonfat dry milk), and number of washes (3) (4) (5) were also tested.
ELISA procedure. The final assay selected was an indirect double antibody sandwich antigen-capture ELISA for detection of BoTV. Briefly, paired rows of a 96-well microtiter plate f were coated with 100 l/well of a 1:1,500 dilution of GP hyperimmune anti-BoTV serum or a 1:1,500 dilution of BoTV antibody-negative GP serum in carbonate-bicarbonate buffer (pH 9.6) and incubated at 4 C overnight. After incubation and at each wash step, the plates were rinsed 4 times with 250 l/well of PBS/0.05% Tween 20, pH 7.2 (PBS/ Tw). Subsequently, the plates were blocked for 2 hr at 25 C or overnight at 4 C with 200 l of 5% nonfat dry milk in PBS (pH 7.2) to minimize nonspecific binding. Then, 100 l of the test samples (1:10 dilution of feces in PBS) were placed in paired wells coated with BoTV antibody-positive or -negative serum and incubated for 1.5 hr at room temperature. A secondary antibody (100 l of purified Gn calf hyperimmune anti-BoTV serum) diluted 1:3,000 in PBS/Tw/ 2% bovine serum albumin (BSA) was applied for 1 hr at 25 C. Next, 100 l of a commercial goat anti-bovine IgG conjugated to horseradish peroxidase e (diluted 1:1,000-2,500 in PBS/Tw/BSA) were added, and the plates were incubated for 1 hr at 25 C. Reactions were developed using 100 l of the chromogen substrate 2,2Ј-azino-bis(3-ethyl-benzthiazoline) sulfonic acid in 0.1 M sodium citrate plus H 2 O 2 (1: 1,000). After 20 min, the absorbance values were read with a computer-linked ELISA plate reader. g A spreadsheet program h was used to calculate the ELISA value (EV) and ELISA ratio (ER) for each corresponding sample. The EV was defined as the average absorbance of the paired BoTV antibody-positive-coated wells minus the average absorbance of the paired BoTV antibody-negative-coated wells. The ER was expressed as the ratio of the average absorbance of the paired BoTV antibody-positive wells to the average absorbance of the paired BoTV antibody-negative wells.
ELISA repeatability. From each original reference sample, 2-3 fecal suspensions were prepared at different intervals. Then, each fecal suspension was tested at least twice by ELISA, and the results were recorded in a spreadsheet program. h Therefore, every sample was tested at least 4-5 times before including an average reading of that individual sample in the statistical analysis.
Determination of the fixed cutoff values. Thirty-four IEMpositive and 29 IEM-negative fecal samples (described earlier) were tested by ELISA to determine the fixed cutoff value (FCV), which was defined as the point at which the highest efficiency (the mathematical product of sensitivity ϫ specificity) 29 for the ELISA was obtained. Therefore, the sensitivity, specificity, and efficiency of the assay were calculated across a range of cutoff values, from 1 to Ͼ2 for the ER, and from 0.01 to Ͼ0.2 for the EV to determine the optimal value to be used as the FCV. On the basis of the results obtained, the highest efficiency obtained would be at the optimum cutoff values (ER and EV) for this particular ELISA. The selected numerical cutoff values were calculated only once and used throughout the ELISA standardization process, and during the comparison of the 4 cutoff values (fixed cutoff EV, fixed cutoff ER, plate cutoff EV [PCEV], and plate cutoff ER) evaluated in this study.
Determination of the plate cutoff values. The PCV was defined as the numerical value calculated on each plate using several known positive and negative controls. The ER or EV results of each individual sample from this plate were compared against the PCV to classify each sample as negative or positive. Six controls (1 known positive and 5 randomly selected negative reference fecal samples) were used on each plate to calculate the PCV based on previous work. 15 Briefly, the mean of the EV of the negative control samples was added to 2.631 (f value) standard deviations (SDs) of the EV of the negative control samples (cutoff ϭ mean ϩ f ϫ SD). The f value was obtained from a table provided by Frey et al. 15 and depends on the number of negative samples included on each plate. This formula was used to calculate the upper limit of the distribution of the negative control samples, such that there was a 95% confidence level that all negative samples would be below that point. The same procedure was used to calculate the PCV for the ER. The sensitivity, specificity, and efficiency of the ELISA were calculated using the PCV for both the EV and the ER to classify the reference samples, and these results were compared against those of the fixed cutoff EV and fixed cutoff ER.
Fixed cutoff value versus PCV. Four cutoff values (fixed cutoff EV, fixed cutoff ER, PCEV, and plate cutoff ER) were compared against the IEM status to determine which value provided the highest sensitivity, specificity, and efficiency in this ELISA. A Kappa value was calculated to measure the agreement between the 4 ELISA cutoff values with the IEM results using the reference samples. The optimal cutoff EV was used as the standard cutoff value during the comparison of the 3 assays tested in this study, ELISA, IEM and RT-PCR.
Optimization of the RT-PCR assay
Design and testing of primers. The primers for BoTV were designed in our laboratory using published sequence data for the spike gene of the BoTV serotype II. 13 The sequences were as follows: upstream primer or spike 5Ј (S5), 5Ј GTG TTA AGT TTG TGC AAA AAT G 3Ј (position 37-57); and downstream primer or spike 3Ј (S3), 5Ј TGC ATG AAC TCT ATA TGG TGT 3Ј (position 758-777). The predicted RT-PCR product was 741 base pairs from the 5Ј end region of the spike gene.
Development and standardization of RT-PCR. To optimize the assay several combinations of the different reagents, as well as different incubation periods, temperatures, and number of cycles were tested. Fecal samples known to be either IEM positive or negative for BoTV were tested with each protocol. The optimal combination was selected based on the highest yield of amplicons and the fewest nonspecific reactions detected.
Reverse transcriptase-polymerase chain reaction procedure. A total RNA isolation reagent for liquid samples i was used for RNA extraction from all fecal samples. The 1-step RT-PCR was performed as follows: 4 l of the extracted RNA were pretreated with 1 l of dimethyl sulfoxide for 10 min at 70-75 C. Then, 5 l of the pretreated RNA sample was mixed with the RT-PCR mixture(5 l of 10ϫ commercial buffer, j . The mixture was overlaid with mineral oil and subjected to 1 RT phase of 90 min at 42 C, an initial denaturation step of 5 min at 94 C, and 30 cycles of 1 min at 94 C, 2 min at 55 C, 2 min at 72 C. The final extension step was 10 min at 72 C. The RT-PCR products were visualized on 1.5% agarose gels stained with ethidium bromide, and their size was determined by comparison against DNA molecular weight markers. Several RT-PCR products were submitted for sequencing to the OARDC/OSU Molecular and Cellular Imaging Center to confirm the specificity of the nucleotide sequence as BoTV. Sequence analysis of the RT-PCR products was performed using a computer software n and compared with data published in GenBank.
Analytical sensitivity of the ELISA and RT-PCR assays
To determine the analytical sensitivity of both tests, 2-fold serial dilutions of 8 hemagglutination units (HAUs) of purified BoTV were tested using both assays. The maximum detection titer for each assay was expressed as the reciprocal of the highest dilution that produced a positive result.
ELISA and RT-PCR versus IEM
The sensitivity and specificity of the ELISA and RT-PCR compared with IEM as the gold standard were calculated. A McNemar chi square for correlated proportions was used for the comparison of the various ELISA cutoff values. Kappa values were calculated for both ELISA and RT-PCR to measure the agreement with the IEM results.
Results
Enzyme-linked immunosorbent assay. The hyperimmune GP and Gn calf sera had HI antibody titers (the reciprocal of the highest serum dilution that inhibited 8 HAU of BoTV) of 1:1,280-2,560 and 1: 5,120 inhibition hemagglutination units (IHAUs), respectively. The negative GP and Gn calf sera did not have HI titers to BoTV (Ͻ5 IHAU). The optimal combination of reagents for use in our ELISA was GP hyperimmune serum (1:1,500) for coating and bovine antiserum (1:3,000) for secondary antibody. This combination had the lowest background and the highest observed difference between the positive and negative fecal samples. The EV and ER calculations were used to compare each fecal sample against its own background signal.
The frequency distribution of the EVs and ERs for the 63 reference samples were calculated and are illustrated in Fig. 1 . The negative samples followed a normal distribution; however, the positive samples were skewed to the right of a normal distribution curve because of specimens with high concentrations of virus. From the frequency distribution data, the sensitivity, specificity, and efficiency of the ELISA assay across a diverse range of cutoff values for the ERs and for the EVs of the reference samples were calculated (Fig. 2) . On the basis of these results and using the calculations for efficiency, which provides the probability of correct classification given a single sample of unknown status, 29 the optimum cutoff values for this particular ELISA were 1.25 for the ERs and 0.05 for the EVs.
The results from reference samples were then analyzed to calculate the sensitivity, specificity, and efficiency of each of the previously described ELISA cutoff values (fixed cutoff EV, fixed cutoff ER, PCEV, and plate cutoff ER), using IEM as a gold standard (Fig. 3) . The PCEV showed the highest efficiency (80%) with 84% and 95% sensitivity and specificity, respectively, when compared with the other 3 cutoff values. The difference observed among the 4 ELISA cutoff values was statistically significant (P Ͻ 0.05). Therefore, the PCEV was chosen as the optimal method to calculate the cutoff value to determine the status of an unknown sample by this ELISA, and it was used as the standard cutoff value for the comparison of the ELISA test against IEM and RT-PCR.
Reverse transcriptase-polymerase chain reaction. The product obtained from the RT-PCR assay was approximately 741 base pairs and showed 93-95% nucleotide homology with that reported for BoTV serotype II in GenBank (accession number AF076621). Figure 2 . Sensitivity, specificity, and efficiency of the BoTV antigen-capture ELISA illustrating the optimum cutoff values (vertical lines) that minimize errors (false positives and false negatives) for both the fixed EV and the fixed ER. Figure 3 . Sensitivity, specificity, and efficiency of the BoTV antigen-capture ELISA based on the Fixed and PCVs, using IEM as the gold standard test.
The RT-PCR had 90% sensitivity, 100% specificity, and 90% efficiency when compared with IEM. Some of the IEM-positive reference samples were negative by RT-PCR initially, apparently due to inhibitors present in the fecal samples. Using a higher dilution of the original fecal sample, it was possible to overcome the effect of such inhibitors and obtain positive reactions. No samples containing bovine coronavirus, rotavirus, or calicivirus produced any RT-PCR products with the BoTV primers used.
ELISA versus RT-PCR. Kappa values were calculated for ELISA and RT-PCR assays to measure the agreement of each with IEM. The Kappa value was 0.86 for the ELISA test using the PCEV as the optimum cutoff and 0.85 for the RT-PCR test. These kappa values did not differ statistically. When both tests were compared on the basis of their analytical sensitivities, the maximum detection titer of the ELISA test using the PCEV as cutoff value was 1:320. The RT-PCR showed a higher analytical sensitivity of 1:10,240.
Longitudinal performance of the tests. The IEM test detected a few BoTV particles as early as 24-36 hours postinoculation (PI) or as late as 8 days PI. However, the majority of the positive samples were detected at 48 hours PI and later. In comparison, the ELISA test also detected BoTV positive samples at 36 hours PI, but the highest readings were obtained after 48-72 hours PI; readings then declined after 4 days PI, becoming negative by day 6. On the other hand, the RT-PCR detected viral RNA as early as 24 hours PI (weak bands) and as late as at least 8 to 9 days PI (further testing was not performed). Nevertheless, the most consistent range for RT-PCR positive samples was between 2-6 days PI.
Discussion
Bovine Torovirus is an enteric pathogen infecting cattle of different ages. 35 To study the epidemiology and characterize BoTV, it is necessary to develop rapid and reliable diagnostic techniques, applicable to large numbers of samples. In this study, 2 tests to detect 2 BoTV components were developed and standardized: antigen by ELISA and viral nucleic acid by RT-PCR. These assays were compared with IEM to determine their sensitivity, specificity, and efficiency as well as their advantages and limitations.
The PCEV previously described by others 15 was the best method to calculate the cutoff value for this ELISA and provided the highest sensitivity and specificity. Although, the FCVs offered the benefit of only being calculated once, they had several disadvantages. The FCVs did not take into account the day-to-day variability observed in the ELISA, and they had to be recalculated each time a new reagent was used. In addition, the accurate calculation of the FCVs to predict the status of an unknown sample required a higher number of positive and negatives samples than used here to include all possible variations of backgrounds and BoTV concentrations. This study clearly shows how the accuracy of ELISA can be determined by the selection of the cutoff value.
Although electron microscopy, ELISA, and RT-PCR have been used for the study of BoTV, 2, 3, 9, 13, 20, 21 to date no previous investigators have compared these assays. The ELISA test is a rapid and inexpensive assay to screen large numbers of samples. 10 However, because BoTV is a fastidious virus that does not grow in vitro and can only be propagated by passage in Gn or CD calves, 17 there is a potential for high background when using purified feces or intestinal contents as the BoTV source, as was observed in this study. The background in this ELISA may be due to the presence of extraneous proteins in the purified virus suspension obtained from fecal samples. These foreign proteins could trigger the production of nonspecific antibodies in the polyclonal hyperimmune antisera, producing cross-reactions with other antigens besides BoTV present in field samples and decreasing the sensitivity and specificity of the ELISA test.
Surprisingly, the RT-PCR assay did not have a higher Kappa value than the ELISA test. This may be due to some IEM-positive samples having inhibitory factors precluding their detection by RT-PCR and decreasing the sensitivity of the test. To overcome this inhibition, several manipulations were tried such as using a higher sample dilution (1:100) or by performing a high-speed centrifugation of the fecal suspension before the RNA extraction. In most cases the inhibition was overcome; however, some IEM-positive samples remained undetectable by RT-PCR, affecting the kappa value for the RT-PCR assay. This phenomenon should be considered when using RT-PCR for fecal samples of unknown BoTV status because a negative result may be a false negative due to inhibitory factors.
Despite the effect of RT-PCR inhibitors, the RT-PCR assay was more sensitive than ELISA. However, the high detection rate of BoTV by RT-PCR poses the question of whether the RT-PCR assay is a suitable test to study the epidemiology of BoTV. Although the RT-PCR assay can be used to detect very low concentrations of BoTV RNA, it is possible that the BoTV RNA detected does not represent a clinical infection but just pass-through virus or BoTV shedding representing subclinical infections that do not have an effect on performance or the manifestation of clinical signs.
The IEM technique is an important epidemiological tool that is limited in its use because it is labor intensive, time consuming, may have low sensitivity requiring virus titers of 10 5 PFU 27 and requires expensive equipment. However, this assay has good specificity when used to detect BoTV because of the identification of the typical morphology of the virus 30 and the presence of agglutination with antibodies to BoTV. Because of the morphological resemblance of BoTV to BCV, it is important to apply IEM instead of simple EM so that both viruses can be differentiated on the basis of agglutination in the presence of the homologous antisera. The BoTV is not agglutinated with anti-BCV antiserum and vice versa. 34, 35 Of the 3 assays examined, no single test may be entirely reliable for epidemiological surveys because of certain disadvantages observed for each test. The ELISA test showed good agreement with the IEM results. However, the ELISA specificity was lower than that for RT-PCR, allowing for an increased risk of false positives. In addition, because of the higher back-ground associated with this ELISA, one can also expect false negative results. In the case of the RT-PCR assay, although it had a very high analytical sensitivity, its real sensitivity is compromised by the presence of inhibitory factors that block true positive samples from being detected by this assay, producing false negatives. Concerning IEM, this technique is useful for the diagnosis of BoTV in fecal samples; however, the use of IEM for large numbers of specimens for epidemiological studies is impractical. Readers should be aware that the sensitivity and specificity results obtained from the comparison of these tests were acquired using samples from Gn and CD calves of known BoTV infection status. Therefore, the extrapolation of these results to the field setting should be done with caution.
In conclusion, the ELISA and RT-PCR assays developed identified BoTV antigen and viral nucleic acids, respectively, in feces. The use of the indirect double sandwich BoTV antigen-capture ELISA provides an effective method for screening large numbers of samples for the presence of BoTV antigen and could be beneficial for large epidemiological studies. However, it is recommended that borderline samples detected by ELISA be tested by RT-PCR (or IEM) to confirm the presence of BoTV. The RT-PCR test and IEM are more time consuming and costly than the ELISA, and for now they may be impractical for use in large-scale epidemiological studies. The ELISA along with the highly specific and sensitive RT-PCR assay provides a practical approach for further studies of BoTV. k. AMV-RT, Promega, Madison, WI. l. RNasin, Promega, Madison, WI. m. Taq polymerase, Promega, Madison, WI. n. Lasergene, DNASTAR Inc, Madison, WI.
